In the media

Back to news lobby
Back to news lobby
In the Media 2 mins
June 10, 2022

High Throughput Hematological Analysis Platform Receives FDA Clearance

Scopio Labs announced that its X100HT device with Peripheral Blood Smear (PBS) Application has received U.S. FDA 510(k) clearance. Coupling high throughput capabilities with the highest resolution for...
Link to full article

Scopio Labs announced that its X100HT device with Peripheral Blood Smear (PBS) Application has received U.S. FDA 510(k) clearance. Coupling high throughput capabilities with the highest resolution for hematological analysis, the X100HT caters to major medical facilities and labs across the world.

Back to news lobby
Latest press releases and coverage
Press Release
July 25, 2024

Scopio Labs Secures $42 Million in Funding Led by Fortissimo Capital

New Funding to Accelerate Scopio Labs' Commercial Growth and Product Innovation in Full-Field Digital Cell Morphology
Read more
Press Release
April 17, 2024

Scopio Labs Receives Groundbreaking FDA Clearance for First-Ever Digital Bone Marrow Aspirate Application

The company’s 3rd FDA clearance accelerates the shift to AI-powered digital hematopathology, enhancing diagnostic speed and patient care.
Read more
In the Media
December 15, 2023

Nine revolutionary ways AI is advancing healthcare

Healthcare organizations and technology companies must work together to ensure responsible and ethical AI use and to explore the true benefits of AI.
Link to full article

Experience high resolution digital imaging and AI-driven full-field analysis

Book a demo